Loading clinical trials...
Loading clinical trials...
The goal of this cross-sectional observational study is to evaluate the relation between Prothrombin induced by vitamin K absence II (PIVKA-II) and the presence of portal vein tumor thrombosis (PVTT) ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Tanta University
NCT07267806 · Hepato Cellular Carcinoma (HCC), Chemotherapy Effect
NCT07148310 · Hepato Cellular Carcinoma (HCC)
NCT06812039 · Hepato Cellular Carcinoma (HCC)
NCT06742424 · Hepato Cellular Carcinoma (HCC)
NCT07328009 · Hepato Cellular Carcinoma (HCC)
Tanta University Hospitals
Tanta, Gharbyea
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions